Pancreatic Cancer Basics
608 articles
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
Let’s Win Rings the Nasdaq Closing Bell for Pancreatic Cancer Awareness Month
Let’s Win marked Pancreatic Cancer Awareness Month by ringing the closing bell at the Nasdaq Stock Market on Monday November 12, 2018.
Let’s Win Pancreatic Cancer Launches an Updated Platform
Let’s Win Pancreatic Cancer has launched its new website, with more ways for patients and caregivers to find important information they need.
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
Let’s Win in a Spectrum News NY1 Report for Pancreatic Cancer Awareness Month
Cindy Gavin and Dr. Allyson Ocean appeared in a Spectrum News NY1 report on a pancreatic cancer patient, for Pancreatic Cancer Awareness Month.
Be Your Own Best Advocate
After being diagnosed with pancreatic cancer, long-term survivor Chris Parrish found she had to be her own advocate to get a chance at survival.
Have Hope
Andy Seynaeve has undergone many rounds of chemotherapy but he has had a great response. Best of all, he has hope.
Presurgical Treatment for Pancreatic Cancer That Is Removable
A clinical trial looks at immunotherapy plus vitamin D plus standard chemotherapy before surgery to remove pancreatic cancer.
Testing Immunotherapy for Safety Before and After Pancreatic Cancer Removal
Researchers are testing a new monoclonal antibody to see if it helps patients with pancreatic tumors that can be surgically removed.
Slowing the Spread of Advanced Pancreatic Cancer
Researchers are testing a kinase inhibitor that is used to treat lung diseases, including a type of lung cancer, against pancreatic cancer.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
Reopening America: Guidelines For Pancreatic Cancer Patients
As states begin to reopen their economies, the threat of COVID-19 remains. Dr. Allyson Ocean has recommendations for pancreatic cancer patients.